<DOC>
	<DOCNO>NCT01759836</DOCNO>
	<brief_summary>Biochemical recurrence develop approximately 30-40 % men locally advanced prostate cancer undergo radical prostatectomy . To date , effect statin prostate cancer recurrence investigate several retrospective study inconsistent result . The purpose study determine impact statin biochemical recurrence radical prostatectomy locally advanced prostate cancer .</brief_summary>
	<brief_title>Impact Adjuvant Statin Therapy Patients Who Underwent Radical Prostatectomy Locally Advanced Prostate Cancer</brief_title>
	<detailed_description>Estimated Enrollment : 354 Study start date : October 2012 Estimated Study Completion Date : October 2015 Statin Group : Treatment Atorvastatin 20mg daily radical prostatectomy 1 year . Control Group : Treatment Placebo daily radical prostatectomy 1 year . Follow : every 3 month first year . Check PSA , Total/LDL-cholesterol Triglyceride . Primary End Point Rate Biochemical recurrence Secondary End Point Clinical progression prostate cancer Change Total/LDL- cholesterol Triglycerides 5 year-Biochemical recurrence free survival</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>1 . Patients must correspond one follow three pathologic criterion . A. Gleason score 8 great B . Positive resection margin C. pT3T4 2 . Patients must pathologically adenocarcinoma 3 . Patients must enrol within 60 day radical prostatectomy 4 . Patients must able provide write informed consent 1 . Patients receive neoadjuvant androgen deprivation therapy 2 . Patients participation clinical trial within past 3 month 3 . Patients treat statin 4 . Patients lymph node metastasis distant metastasis 5 . Patients 10 year risk cardiovascular disease 10 % base NCEP ATP III guideline .</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Prostatectomy</keyword>
	<keyword>Statins</keyword>
</DOC>